During the past decade, Thoraxklinik-Heidelberg Zentrum für Pulmonale Hypertonie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Thoraxklinik-Heidelberg Zentrum für Pulmonale Hypertonie" are "Cardiovascular Diseases" (2 trials), "Connective Tissue Diseases" (2 trials), "Familial Primary Pulmonary Hypertension" (2 trials), "Hypertension" (2 trials) and "Hypertension, Pulmonary" (2 trials). Many other conditions were trialed in "Thoraxklinik-Heidelberg Zentrum für Pulmonale Hypertonie" in a lesser frequency.

Most popular intervention types in "Thoraxklinik-Heidelberg Zentrum für Pulmonale Hypertonie" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ralinepag" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Thoraxklinik-Heidelberg Zentrum für Pulmonale Hypertonie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Thoraxklinik-Heidelberg Zentrum für Pulmonale Hypertonie". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in Thoraxklinik-Heidelberg Zentrum für Pulmonale Hypertonie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Thoraxklinik-Heidelberg Zentrum für Pulmonale Hypertonie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".